FedEx Features AditxtScore™ Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of Quantifying Immune Health
Aditxt, Inc.’s (NASDAQ: ADTX) (“Aditxt”, or the
“Company”) AditxtScore™ is featured by FedEx in a video
presentation that showcases the various ways in which both
companies are playing critical roles in a challenging environment
that includes the nation’s response to COVID-19.
In the clip, the Aditxt team provides a virtual tour of its
AditxtScore™ Center, while describing how the Company works
with scientists and technicians to process samples from around the
country to help physicians and health care professionals identify
and understand their patients’ immune status.
Blood specimens from physicians, clinics, and hospitals are
delivered by FedEx in a system that relies on speed, precision, and
attention to detail. AditxtScore™ chose to work with FedEx
based upon a track record of timely delivery, since maintaining the
stability of each sample is critical to the Company’s business.
Aditxt then processes the samples using proprietary technologies
and generates a personalized profile of the individual’s level of
immune response to the COVID-19 virus or vaccine.
“Aditxt is a biotech innovation company with a very special
mission — understanding our immune status and our immune system by
the numbers,” said Amro Albanna, co-founder and CEO of Aditxt.
“AditxtScore™ is a technology and service platform with a proactive
approach, meaning the ongoing monitoring of immune status, so we
can be better prepared for dealing with such threats as COVID-19.
Having a company like FedEx, with their logistical capabilities, is
key to scaling AditxtScore™.”
The FedEx Clinical Care end-to-end solution provides specialized
shipping that meet the exacting needs of healthcare customers like
AditxtScore™ reports equip physicians and patients with
vital data, so they are better able to understand their immunity
levels against COVID-19 and make an informed decision on the right
time for a vaccine booster or answer questions about other medical
About Aditxt, Inc.
Aditxt is a biotech innovation company developing and
commercializing technologies with a focus on monitoring and
modulating the immune system. Aditxt’s immune monitoring
technologies are designed to provide a personalized immune profile.
Aditxt’s immune reprogramming technologies, currently preclinical,
are being developed to retrain the immune system to induce
tolerance to address rejection of transplanted organs, autoimmune
diseases, and allergies.
For more information, please visit www.Aditxt.com and
Certain statements in this press release constitute
"forward-looking statements" within the meaning of federal
securities laws. Forward-looking statements include statements
regarding the Company's intentions, beliefs, projections, outlook,
analyses or current expectations concerning, among other things,
the Company's ongoing and planned product and business development;
the Company's intellectual property position; the Company's ability
to develop commercial functions; expectations regarding product
launch and revenue; the Company's results of operations, cash
needs, spending, financial condition, liquidity, prospects, growth
and strategies; the industry in which the Company operates; and the
trends that may affect the industry or the Company. Forward-looking
statements are not guarantees of future performance and actual
results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, as well as market and other conditions and those risks
more fully discussed in the section titled "Risk Factors" in the
Company's most recent Annual Report on Form 10-K, as well as
discussions of potential risks, uncertainties, and other important
factors in the Company's other filings with the Securities and
Exchange Commission. All such statements speak only as of the date
made, and the Company undertakes no obligation to update or revise
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
version on businesswire.com: https://www.businesswire.com/news/home/20221007005041/en/
Media and Investor Relations Contact: email@example.com
Historical Stock Chart
From Nov 2022 to Dec 2022
Historical Stock Chart
From Dec 2021 to Dec 2022